Edward M Kerwin
13PUBLICATIONS
17CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (13)
Sort by Publication Date:
|Oct 06, 2023
How can the findings of the EMAX trial on long-acting bronchodilation in chronic obstructive pulmonary disease be applied in the primary care setting?Edward M Kerwin, Paul W Jones, Leif H Bjermer
|Feb 11, 2022
Initial analysis of viral dynamics and circulating viral variants during the mRNA-1273 Phase 3 COVE trial.Rolando Pajon, Yamuna D Paila, Bethany Girard
|Dec 17, 2021
Economic Evaluation of Umeclidinium/Vilanterol versus Umeclidinium or Salmeterol in Symptomatic Non-Exacerbating Patients with COPD from a UK Perspective Using the GALAXY Model.Soham Shukla, Dhvani Shah, Alan Martin
|Aug 04, 2021
Efficacy and Safety of Umeclidinium/Vilanterol in Current and Former Smokers with COPD: A Prespecified Analysis of The EMAX Trial.Leif H Bjermer, Isabelle H Boucot, Claus F Vogelmeier
|Jul 08, 2021
Dual Bronchodilator Therapy as First-Line Treatment in Maintenance-Naïve Patients with Symptomatic COPD: A Pre-Specified Analysis of the EMAX Trial.Leif Bjermer, Isabelle H Boucot, François Maltais
|May 12, 2021
Treatment of COPD with Long-Acting Bronchodilators: Association Between Early and Longer-Term Clinically Important Improvement.Claus F Vogelmeier, Ian P Naya, François Maltais
Pageof 3
Frequent Collaborators
5 joint publications
David A Lipson
4 joint publications
Isabelle H Boucot
4 joint publications
Leif H Bjermer
4 joint publications
Paul W Jones
4 joint publications
François Maltais
2 joint publications
Claus F Vogelmeier
1 joint publications
Soham Shukla
1 joint publications
Alan Martin
1 joint publications
Robyn Kendall
1 joint publications
Afisi S Ismaila
